Chapter title |
Endocannabinoids and the Immune System in Health and Disease.
|
---|---|
Chapter number | 6 |
Book title |
Endocannabinoids
|
Published in |
Handbook of experimental pharmacology, January 2015
|
DOI | 10.1007/978-3-319-20825-1_6 |
Pubmed ID | |
Book ISBNs |
978-3-31-920824-4, 978-3-31-920825-1
|
Authors |
Cabral, Guy A, Ferreira, Gabriela A, Jamerson, Melissa J, Guy A. Cabral, Gabriela A. Ferreira, Melissa J. Jamerson, Cabral, Guy A., Ferreira, Gabriela A., Jamerson, Melissa J. |
Editors |
Roger G. Pertwee |
Abstract |
Endocannabinoids are bioactive lipids that have the potential to signal through cannabinoid receptors to modulate the functional activities of a variety of immune cells. Their activation of these seven-transmembranal, G protein-coupled receptors sets in motion a series of signal transductional events that converge at the transcriptional level to regulate cell migration and the production of cytokines and chemokines. There is a large body of data that supports a functional relevance for 2-arachidonoylglycerol (2-AG) as acting through the cannabinoid receptor type 2 (CB2R) to inhibit migratory activities for a diverse array of immune cell types. However, unequivocal data that supports a functional linkage of anandamide (AEA) to a cannabinoid receptor in immune modulation remains to be obtained. Endocannabinoids, as typical bioactive lipids, have a short half-life and appear to act in an autocrine and paracrine fashion. Their immediate effective action on immune function may be at localized sites in the periphery and within the central nervous system. It is speculated that endocannabinoids play an important role in maintaining the overall "fine-tuning" of the immune homeostatic balance within the host. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 6 | 30% |
United States | 2 | 10% |
United Kingdom | 2 | 10% |
Unknown | 10 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 85% |
Practitioners (doctors, other healthcare professionals) | 2 | 10% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | <1% |
Unknown | 103 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 19 | 18% |
Student > Bachelor | 14 | 13% |
Student > Master | 12 | 12% |
Researcher | 10 | 10% |
Other | 7 | 7% |
Other | 11 | 11% |
Unknown | 31 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 14 | 13% |
Agricultural and Biological Sciences | 13 | 13% |
Biochemistry, Genetics and Molecular Biology | 12 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 11% |
Medicine and Dentistry | 11 | 11% |
Other | 12 | 12% |
Unknown | 31 | 30% |